The long half-life means that even after stopping treatment, side effects can persist for several weeks
J Clin Endocrinol Metab 1982;54:21722.ArticlePubMed 29
Several licensed weight management injectable therapies are available in the UK including semaglutide (Wegovy, approved by NICE for weight management in eligible adults) and tirzepatide (Mounjaro, licensed in the UK for type 2 diabetes and, subject to current NICE guidance, for weight management in eligible adults)
That said, there is some evidence that complaints of GI issues including bloating peak for women in their 40s (when many are in perimenopause, the stage before periods fully stop)
Targeted strengthening should become part of your regular training once acute recovery is complete
Shirzad, H., Mousavinezhad, S